CPC C12N 15/11 (2013.01) [A61K 48/00 (2013.01); C12N 9/22 (2013.01); C12N 15/1132 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0337 (2013.01); C07K 2319/09 (2013.01); C12N 2310/20 (2017.05); C12N 2750/14143 (2013.01)] | 11 Claims |
1. An adeno-associated viral vector serotype 9 (AAV9) expression vector, comprising a nucleic acid sequence encoding:
(a) a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease;
(b) a first guide RNA (gRNA), wherein the first gRNA targets a long terminal repeat (LTR) of a human immunodeficiency virus (HIV) sequence and the nucleic acid sequence encoding the first gRNA comprises any one of the rRNA encoding sequences of SEQ ID NOs: 1-6; and
(c) a second gRNA, wherein the nucleic acid sequence encoding the second gRNA comprises any one of the gRNA encoding sequences of SEQ ID NOs: 11 and 12,
wherein the CRISPR-associated endonuclease, the first gRNA, and the second gRNA are capable of excising intervening sequences between the first target sequence and the second target sequence.
|